Keyphrases
Atrial Fibrillation
100%
Risk Factors
100%
Phosphodiesterase-4 (PDE4)
50%
SNP
25%
Anti-inflammatory Properties
25%
Protein Family
25%
Functional Consequences
25%
Cellular Distribution
25%
Intracellular Distribution
25%
Intracellular Signaling
25%
Enzyme Hydrolysis
25%
Population-based Study
25%
Arrhythmia
25%
Cyclic nucleotides
25%
Complex Proteins
25%
Single nucleotide Polymorphism
25%
Ischemic Stroke
25%
Brain Vasculature
25%
Cardiovascular Disease
25%
Tissue Distribution
25%
Cardiac Risk
25%
Cyclic Adenosine Monophosphate (cAMP)
25%
Vasoreactivity
25%
Pathophysiology
25%
Stroke Treatment
25%
Stroke Disease
25%
Atrial Myocytes
25%
Stroke Patients
25%
PDE4 Inhibitor
25%
Medicine and Dentistry
Atrial Fibrillation
100%
Apoplexy
100%
Single Nucleotide Polymorphism
50%
Pathophysiology
25%
Protein Family
25%
Brain Ischemia
25%
Cardiac Dysrhythmia
25%
Cardiovascular Disease
25%
Phosphodiesterase IV Inhibitor
25%
Vascularity
25%
Anti-Inflammatory Drug
25%
Cyclic Nucleotide
25%
Phosphodiesterase
25%
Intracellular Signaling
25%
Downregulation
25%
Cyclic AMP
25%
Biochemistry, Genetics and Molecular Biology
Atrial Fibrillation
100%
Subcellular Localization
50%
Enzyme
50%
Tissue Distribution
25%
Downregulation
25%
Intracellular Signaling
25%
Cyclic Nucleotide
25%
Phosphodiesterase
25%
Vascularization
25%
Cyclic Adenosine Monophosphate
25%
Protein Family
25%
Single-Nucleotide Polymorphism
25%
Single Nucleotide Polymorphism
25%
Cardiac Dysrhythmia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
100%
Atrial Fibrillation
100%
Cyclic Nucleotide
25%
Pathophysiology
25%
Brain Ischemia
25%
Cardiovascular Disease
25%
Anti-Inflammatory Drug
25%
Phosphodiesterase IV Inhibitor
25%
Heart Arrhythmia
25%
Phosphodiesterase
25%
Cyclic AMP
25%